PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells. (Q46229463)

From Wikidata
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
scientific article published on 28 November 2014
Language Label Description Also known as
English
PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells.
scientific article published on 28 November 2014

    Statements

    Identifiers